secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOXYTRAN, INC (BIXT)
CIK:        0001445815
Form:       8-K
Filed at:   2021-07-16T23:59:59+00:00
Accession:  0001539497-21-001048
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Bioxytran director Henry Esber resigns; Hana Chen-Walden appointed to board
---------------------------------------------------------------------------

- Dr. Henry Esber resigned as director effective July 15, 2021, for medical reasons.
- Hana Chen-Walden, M.D., a Medical Advisory Board member, elected to fill the vacancy.
- Dr. Chen-Walden has 35+ years of regulatory experience; she will receive no cash compensation as director.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1445815/000153949721001048/0001539497-21-001048-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1445815/000153949721001048/n2583-x7_8k.htm
  HTML page:      https://secwatch.observer/filing/0001539497-21-001048

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer